Related Experiment Videos
Chronic hepatitis C. Advances in diagnostic testing and therapy
R A Rubin1, M Falestiny, P F Malet
1Gastroenterology Division, Philadelphia Veterans Affairs Medical Center.
Archives of Internal Medicine
|February 28, 1994
Summary
Diagnosing hepatitis C virus (HCV) infection has advanced, aiding understanding of its natural history. Interferon alfa therapy shows promise for chronic HCV, though long-term outcomes require further study.
Area of Science:
- Hepatology
- Virology
- Immunology
Background:
- Hepatitis C virus (HCV) diagnosis has evolved significantly since 1989.
- Current diagnostics detect viral RNA and antibodies, improving understanding of HCV natural history.
Purpose of the Study:
- To review the diagnostic methods for chronic hepatitis C.
- To examine the efficacy, mechanisms, and adverse effects of interferon alfa therapy for chronic HCV.
Main Methods:
- Review of diagnostic techniques for HCV, including antibody and RNA assays.
- Analysis of data on interferon alfa therapy outcomes and side effects.
Main Results:
- HCV diagnosis has improved, revealing chronic transaminase elevation in nearly 50% of acute cases.
- Cirrhosis affects approximately 20% of chronic infections, potentially linked to hepatocellular carcinoma.
- Interferon alfa therapy achieved sustained normalization in 25% of patients but had potential adverse effects.
Conclusions:
- Improved HCV diagnostics enhance understanding of disease progression.
- Interferon alfa therapy offers a treatment option for chronic HCV with manageable side effects.
- The long-term impact of interferon therapy on cirrhosis and carcinoma risk remains undetermined.